107 related articles for article (PubMed ID: 7520407)
1. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csoka K; Larsson R; Tholander B; Gerdin E; de la Torre M; Nygren P
Gynecol Oncol; 1994 Aug; 54(2):163-70. PubMed ID: 7520407
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
[TBL] [Abstract][Full Text] [Related]
3. Prediction of individual patient response to chemotherapy by the fluorometric microculture cytotoxicity assay (FMCA) using drug specific cut-off limits and a Bayesian model.
Larsson R; Nygren P
Anticancer Res; 1993; 13(5C):1825-9. PubMed ID: 8267387
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
5. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csóka K; Tholander B; Gerdin E; de la Torre M; Larsson R; Nygren P
Int J Cancer; 1997 Sep; 72(6):1008-12. PubMed ID: 9378534
[TBL] [Abstract][Full Text] [Related]
6. The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing.
Haglund C; Aleskog A; Håkansson LD; Höglund M; Jacobsson S; Larsson R; Lindhagen E
Toxicol Lett; 2010 May; 194(3):102-7. PubMed ID: 20167269
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
[TBL] [Abstract][Full Text] [Related]
9. The fluorometric microculture cytotoxicity assay.
Lindhagen E; Nygren P; Larsson R
Nat Protoc; 2008; 3(8):1364-9. PubMed ID: 18714304
[TBL] [Abstract][Full Text] [Related]
10. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
Larsson R; Kristensen J; Sandberg C; Nygren P
Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
[TBL] [Abstract][Full Text] [Related]
11. Isolation and culture of ovarian tumour cells, cytological and cell survival evaluation.
Ingvarsson M; Höckenström T; Lindgren P; Ridderheim M; Bäckström T
Anticancer Res; 1999; 19(6B):5069-73. PubMed ID: 10697512
[TBL] [Abstract][Full Text] [Related]
12. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
13. Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients.
Nygren P; Fridborg H; Csoka K; Sundström C; de la Torre M; Kristensen J; Bergh J; Hagberg H; Glimelius B; Rastad J
Int J Cancer; 1994 Mar; 56(5):715-20. PubMed ID: 8314348
[TBL] [Abstract][Full Text] [Related]
14. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
Nygren P; Hagberg H; Glimelius B; Sundström C; Kristensen J; Christiansen I; Larsson R
Ann Oncol; 1994; 5 Suppl 1():127-31. PubMed ID: 8172809
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.
Tanigawa N; Mizuno Y; Hashimura T; Honda K; Satomura K; Hikasa Y; Niwa O; Sugahara T; Yoshida O; Kern DH
Cancer Res; 1984 Jun; 44(6):2309-12. PubMed ID: 6202397
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
18. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
19. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxic effect of new diphenylphosphinoethane-copper(I) complexes on human ovarian carcinoma cells.
Adwankar MK; Wycliff C; Samuelson A
Indian J Exp Biol; 1997 Aug; 35(8):810-4. PubMed ID: 9475052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
